Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Intravesical BCG therapy as cause of miliary pulmonary tuberculosis.

Rosati Y, Fabiani A, Taccari T, Ranaldi R, Mammana G, Tubaldi A.

Urologia. 2016 Jan-Mar;83(1):49-53. doi: 10.5301/uro.5000130. Epub 2015 Nov 25.

PMID:
26616461
2.

Clinical efficacy and tolerability of an immune-stimulant(*) constituted by inactivated bacterial bodies in the prophylaxis of infectious episodes of airways: a double blind, placebo-controlled, randomized, multicentre study.

Carlone S, Minenna M, Morlino P, Mosca L, Pasqua F, Pela R, Schino P, Tubaldi A, Tupputi E, De Benedetto F; Buccalin Trial Group..

Multidiscip Respir Med. 2014 Nov 19;9(1):58. doi: 10.1186/2049-6958-9-58. eCollection 2014.

3.

Real-life prospective study on asthma control in Italy: cross-sectional phase results.

Allegra L, Cremonesi G, Girbino G, Ingrassia E, Marsico S, Nicolini G, Terzano C; PRISMA (PRospectIve Study on asthMA control) Study Group..

Respir Med. 2012 Feb;106(2):205-14. doi: 10.1016/j.rmed.2011.10.001. Epub 2011 Oct 28.

4.

Rhino-Bronchial Syndrome. The SIO-AIMAR (Italian Society of Otorhinolaryngology, Head Neck Surgery-Interdisciplinary Scientific Association for the Study of the Respiratory Diseases) survey.

Passali D, Benedetto de F, Benedetto de M, Chiaravalloti F, Damiani V, Passali FM, Bellussi LM; Working Group..

Acta Otorhinolaryngol Ital. 2011 Feb;31(1):27-34.

5.

Effect of inhaled glucocorticoids and beta(2) agonists on vertebral fracture risk in COPD patients: the EOLO study.

Gonnelli S, Caffarelli C, Maggi S, Guglielmi G, Siviero P, Rossi S, Crepaldi G, Nuti R; EOLO study group..

Calcif Tissue Int. 2010 Aug;87(2):137-43. doi: 10.1007/s00223-010-9392-x. Epub 2010 Jun 22.

PMID:
20567964
6.

Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial.

Troosters T, Celli B, Lystig T, Kesten S, Mehra S, Tashkin DP, Decramer M; Uplift Investigators..

Eur Respir J. 2010 Jul;36(1):65-73. doi: 10.1183/09031936.00127809. Epub 2010 Feb 25.

7.

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.

Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP; UPLIFT investigators..

Lancet. 2009 Oct 3;374(9696):1171-8. doi: 10.1016/S0140-6736(09)61298-8. Epub 2009 Aug 27.

PMID:
19716598
8.

Osteoporosis risk in patients with chronic obstructive pulmonary disease: the EOLO study.

Maggi S, Siviero P, Gonnelli S, Schiraldi C, Malavolta N, Nuti R, Crepaldi G; EOLO Study Group..

J Clin Densitom. 2009 Jul-Sep;12(3):345-52. doi: 10.1016/j.jocd.2009.05.003.

PMID:
19647671
9.

A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators..

N Engl J Med. 2008 Oct 9;359(15):1543-54. doi: 10.1056/NEJMoa0805800. Epub 2008 Oct 5.

10.

Clinical suspicion as a primary guidance to use commercial amplification tests for rapid diagnosis of pulmonary tuberculosis.

Piersimoni C, Nista D, Zallocco D, Galassi M, Cimarelli ME, Tubaldi A.

Diagn Microbiol Infect Dis. 2005 Nov;53(3):195-200. Epub 2005 Oct 24.

PMID:
16249062
11.

An unusual iatrogenic foreign body (surgical gauze) in the trachea.

Tabuena RP, Zuccatosta L, Tubaldi A, Gasparini S.

Respiration. 2008;75(1):105-8. Epub 2005 Sep 30.

PMID:
16205043
12.

N-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPD.

Pela R, Calcagni AM, Subiaco S, Isidori P, Tubaldi A, Sanguinetti CM.

Respiration. 1999 Nov-Dec;66(6):495-500.

PMID:
10575333
13.

[Clonidine-cyclothiazide combination in the therapy of arterial hypertension. Controlled clinical study after oral administration].

Negri L, Tubaldi A, Giosuè G, Ghergo GF, Geromino A.

Clin Ter. 1983 Nov 30;107(4):271-7. Italian. No abstract available.

PMID:
6230200

Supplemental Content

Loading ...
Support Center